A real-world, multicenter study of atezolizumab plus bevacizumab in viral and non-viral advanced hepatocellular carcinoma patients from Asia and Europe

被引：0

作者：

Rossari, F. ^{[1
]}

Tada, T. ^{[2
]}

Shimose, S. ^{[3
]}

Kudo, M. ^{[4
]}

Yoo, C. ^{[5
]}

Cheon, J. ^{[6
]}

Finkelmeier, F. ^{[7
]}

Lim, H. Y. ^{[8
]}

Presa, J. ^{[9
]}

Masi, G. ^{[10
]}

Bergamo, F. ^{[11
]}

Amadeo, E. ^{[12
]}

Vitiello, F. ^{[13
]}

Foti, S. ^{[14
]}

Camera, S. ^{[12
]}

Persano, M. ^{[15
]}

Stefanini, B. ^{[16
]}

Scartozzi, M. ^{[17
]}

Rimini, M. ^{[12
]}

Gardini, A. Casadei ^{[12
]}

机构：

[1] UniSR Univ Vita & Salute San Raffaele Milano, Dept Med Oncol, SR Tiget, Milan, Italy

[2] Japanese Red Cross Soc Himeji Hosp, Internal Med, Himeji, Japan

[3] Kurume Univ Hosp, Div Gastroenterol, Dept Med, Kurume, Japan

[4] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Japan

[5] Univ Ulsan, Dept Med Oncol, Asan Med Ctr, Seoul, South Korea

[6] Ulsan Univ Hosp, Div Hematol & Oncol, Ulsan, South Korea

[7] Goethe Univ Frankfurt am Main, Gastroenterol Dept, Campus Westend, Frankfurt, Germany

[8] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr SMC, Sch Med, Seoul, South Korea

[9] Ras os Montes & Alto Douro Hosp Ctr, Liver Unit, Vila Real, Portugal

[10] Pisa Univ, Dept Translat Res & New Technol Med & Surg, Pisa, Italy

[11] IOV Ist Oncol Veneto IRCCS, Oncol 1, Padua, Italy

[12] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy

[13] IRCCS Osped San Raffaele, Oncol, Milan, Italy

[14] IRCCS Osped San Raffaele, Dept Oncol, Milan, Italy

[15] AOU Cagliari Osped Civile, Dept Med Oncol, Cagliari, Italy

[16] Imperial Coll London, Oncol, Hammersmith Campus, London, England

[17] Univ Cagliari, Dept Med Oncol, Cagliari, Italy

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.191

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

182P

引用

页码：S82 / S82

页数：1

共 50 条

[31] Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load
Chen, S.
Lai, H.
Tsou, H.
Shao, Y.
Chang, C.
Su, T.
Liu, T.
Chen, L.
Cheng, A.
Hsu, C.
ANNALS OF ONCOLOGY, 2021, 32 : S141 - S142
[32] Letter to the editor: Atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world
Zhang, Junwei
Fang, Jinyu
Xun, Ziyu
Xu, Yiyao
Lu, Xin
Zhao, Haitao
HEPATOLOGY, 2022, 76 (04) : E84 - E85
[33] INITIAL EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE
Iwamoto, Hideki
Shimose, Shigeo
Takashi, Niizeki
Noda, Yu
Shirono, Tomotake
Nakano, Masahito
Okamura, Shusuke
Kamachi, Naoki
Suzuki, Hiroyuki
Kuromatsu, Ryoko
Koga, Hironori
Torimura, Takuji
HEPATOLOGY, 2021, 74 : 652A - 652A
[34] Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice
Iwamoto, Hideki
Shimose, Shigeo
Noda, Yu
Shirono, Tomotake
Niizeki, Takashi
Nakano, Masahito
Okamura, Shusuke
Kamachi, Naoki
Suzuki, Hiroyuki
Sakai, Miwa
Kajiwara, Akira
Itano, Satoshi
Tanaka, Masatoshi
Yamaguchi, Taizo
Kuromatsu, Ryoko
Koga, Hironori
Torimura, Takuji
CANCERS, 2021, 13 (11)
[35] Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
Ando, Yuwa
Kawaoka, Tomokazu
Kosaka, Masanari
Shirane, Yuki
Johira, Yusuke
Miura, Ryoichi
Murakami, Serami
Yano, Shigeki
Amioka, Kei
Naruto, Kensuke
Kosaka, Yumi
Uchikawa, Shinsuke
Kodama, Kenichiro
Fujino, Hatsue
Nakahara, Takashi
Ono, Atsushi
Murakami, Eisuke
Yamauchi, Masami
Okamoto, Wataru
Takahashi, Shoichi
Imamura, Michio
Chayama, Kazuaki
Aikata, Hiroshi
CANCERS, 2021, 13 (16)
[36] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
Yuka Hayakawa
Kaoru Tsuchiya
Masayuki Kurosaki
Yutaka Yasui
Shun Kaneko
Yuki Tanaka
Shun Ishido
Kento Inada
Sakura Kirino
Koji Yamashita
Tsubasa Nobusawa
Hiroaki Matsumoto
Tatsuya Kakegawa
Mayu Higuchi
Kenta Takaura
Shohei Tanaka
Chiaki Maeyashiki
Nobuharu Tamaki
Hiroyuki Nakanishi
Jun Itakura
Yuka Takahashi
Yasuhiro Asahina
Ryuichi Okamoto
Namiki Izumi
Investigational New Drugs, 2022, 40 : 392 - 402
[37] Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting
Falette-Puisieux, Manon
Nault, Jean-Charles
Bouattour, Mohamed
Lequoy, Marie
Amaddeo, Giuliana
Decaens, Thomas
Di Fiore, Frederic
Manfredi, Sylvain
Merle, Philippe
Baron, Aurore
Locher, Christophe
Pellat, Anna
Coriat, Romain
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[38] Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration
Alkadimi, Munaf
Lucero, Kana
Boyle, Lauren Diaz
Fierro, Maria Elena
Franklin, Kathleen
Nooruddin, Zohra
Mader, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[39] Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
D'Alessio, Antonio
Weinmann, Arndt
Galle, Peter R.
Fulgenzi, Claudia Angela Maria
Bettinger, Dominik
Bengsch, Bertram
Vogel, Arndt
Balcar, Lorenz
Scheiner, Bernhard
Navaid, Musharraf
Naqash, Abdul Rafeh
Personeni, Nicola
Pressiani, Tiziana
Sharma, Rohini
Pinter, Matthias
Cortellini, Alessio
Rimassa, Lorenza
Pinato, David James
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[40] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
Hayakawa, Yuka
Tsuchiya, Kaoru
Kurosaki, Masayuki
Yasui, Yutaka
Kaneko, Shun
Tanaka, Yuki
Ishido, Shun
Inada, Kento
Kirino, Sakura
Yamashita, Koji
Nobusawa, Tsubasa
Matsumoto, Hiroaki
Kakegawa, Tatsuya
Higuchi, Mayu
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Tamaki, Nobuharu
Nakanishi, Hiroyuki
Itakura, Jun
Takahashi, Yuka
Asahina, Yasuhiro
Okamoto, Ryuichi
Izumi, Namiki
INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 392 - 402

← 1 2 3 4 5 →